Susan G. Komen Strengthens Leadership With Strategic Appointments to Board of Directors
Susan G. Komen Strengthens Leadership With Strategic Appointments to Board of Directors
Leaders In Oncology, Finance and Technology Join Forces for Breast Cancer Advancement
肿瘤学、金融和技术领域的领导者联手推动乳腺癌发展
DALLAS, March 20, 2024 /PRNewswire/ -- Susan G. Komen, the world's leading breast cancer organization, today announced four new global leaders to serve on its Board of Directors. These appointments mark a significant milestone in the organization's continued commitment to advancing breast cancer research, awareness and support. The newly appointed board members bring a wealth of experience and expertise to the organization, further fortifying Komen's mission to end breast cancer forever.
达拉斯，2024 年 3 月 20 日 /PRNewswire/ — Susan G. Komen世界领先的乳腺癌组织今天宣布了四位新的全球领导人加入其董事会。这些任命标志着该组织持续致力于推进乳腺癌研究、宣传和支持的一个重要里程碑。新任命的董事会成员为该组织带来了丰富的经验和专业知识，进一步巩固了Komen永远终结乳腺癌的使命。
With a combined expertise in oncology, finance and technology investment, the addition of Kim Blackwell, Elizabeth de-Saint Aignan, Charles Rockefeller and Kathy Sutherland underscores the organization's commitment to crafting a dynamic and influential leadership team, poised not just for change, but to spearhead transformative initiatives.
Kim Blackwell、Elizabeth de-Saint Aignan、Charles Rockefeller和Kathy Sutherland的加入凸显了该组织致力于打造一支充满活力和影响力的领导团队，不仅为变革做好准备，而且要带头实施变革性举措。
"Komen's new board members join a legacy of passionate individuals who have dedicated themselves to making a difference," said Paula Schneider, president & CEO, Susan G. Komen. "As I often say, ending breast cancer will take a village—and with these four new powerhouse leaders on board, we are sure to amplify our impact on the lives of countless families nationwide, positioning us to make even greater strides in our mission to end breast cancer forever."
苏珊·科门总裁兼首席执行官宝拉·施耐德表示：“Komen的新董事会成员继承了充满激情的个人的遗产，他们致力于有所作为。“正如我经常说的那样，终结乳腺癌需要一个村庄的努力，有了这四位新的强国领袖，我们一定会扩大对全国无数家庭生活的影响，使我们能够在永远终结乳腺癌的使命方面取得更大的进步。”
The new members are:
新成员是：
Kim Blackwell, Chief Executive Officer at Zentalis Pharmaceuticals, joins the board with an impressive background in oncology clinical development. Her tenure at Duke University Cancer Institute and leadership roles in the pharmaceutical industry showcase her commitment to advancing cancer research and treatment. Blackwell holds a B.A. degree in Bioethics from Duke University and an M.D. degree from Mayo Clinic Medical School.
金·布莱克威尔， Zentalis Pharmicals 首席执行官， 加入董事会时拥有令人印象深刻的肿瘤学临床开发背景。她在杜克大学癌症研究所任职以及在制药行业担任的领导职务表明了她对推进癌症研究和治疗的承诺。Blackwell 拥有杜克大学生物伦理学学士学位和梅奥诊所医学院医学博士学位。
Elizabeth de-Saint Aignan, General Partner, Head of North America for Late Stage Growth Fund at AVP, is a seasoned private equity and venture capital investor with 25 years of experience investing in rapidly growing technology companies. She is currently responsible for AVP's Late Stage Growth Equity Fund. Holding an MBA with distinction from Harvard Business School, de-Saint Aignan's expertise will be invaluable as Komen continues to explore innovative approaches in its mission to combat breast cancer.
伊丽莎白·德圣·艾尼昂， 普通合伙人，AVP后期增长基金北美负责人， 是一位经验丰富的私募股权和风险投资者，在快速增长的科技公司投资方面拥有25年的经验。她目前负责AVP的后期增长股票基金。De-Saint Aignan以优异成绩拥有哈佛商学院的工商管理硕士学位，随着Komen继续探索其抗击乳腺癌的使命的创新方法，他的专业知识将是无价的。
Charles Rockefeller, CuraPatient, Inc., Co-Founder brings pioneering expertise in innovative AI-enabled digital health platforms. CuraPatient, utilized by the U.S. Department of Veterans Affairs, offers intuitive care plans, patient engagement tools, and automated administration. Recognized for its top-tier cybersecurity and government interoperability, CuraPatient is among just 21 companies with FedRamp High certification. It also won first prize in a Tech Sprint competition hosted by the National Institute of Artificial Intelligence, cementing its leadership in healthcare innovation.
查尔斯·洛克菲勒，CuraPatient, Inc.，联合创始人 在支持人工智能的创新数字健康平台方面带来了开创性的专业知识。美国退伍军人事务部使用的 CuraPatient 提供直观的护理计划、患者参与工具和自动化管理。CuraPatient因其顶级网络安全和政府互操作性而受到认可，是仅有的21家获得FedRAMP高级认证的公司之一。它还在国家人工智能研究所主办的Tech Sprint竞赛中获得一等奖，巩固了其在医疗创新领域的领导地位。
Kathy Sutherland, Partner & Chief Executive Officer at GoldenTree Asset Management, brings a wealth of financial acumen and strategic leadership to the board. She is also a member of GoldenTree's Executive Committee. Sutherland oversees the firm's global strategy, product and business development, and long-term planning. Formerly Managing Director at J.P. Morgan, she led Fund and Structured Product Distribution across the Americas, Europe, the Middle East and Asia. With a B.A. in chemistry from the University of Virginia, Sutherland has held various key roles in Portfolio Management, Structured Credit, and High Yield.
凯西·萨瑟兰，金树资产管理合伙人兼首席执行官， 为董事会带来丰富的财务头脑和战略领导力。她还是金树执行委员会的成员。萨瑟兰监督公司的全球战略、产品和业务发展以及长期规划。她曾任摩根大通董事总经理，领导美洲、欧洲、中东和亚洲的基金和结构性产品分销。萨瑟兰拥有弗吉尼亚大学化学学士学位，曾在投资组合管理、结构性信贷和高收益领域担任过各种关键职务。
Ed Dandridge, Executive VP & Chief Marketing/Communications Officer at AIG, will continue to serve as the Chairman of the Board and Jerri Johnson, VP of Workforce Management Technology at Sony Pictures Entertainment, as Vice Chair of the Board.
埃德·丹德里奇，美国国际集团执行副总裁兼首席营销/传播官， 将继续担任董事会主席和 杰里·约翰逊，索尼影视娱乐公司劳动力管理技术副总裁，担任董事会副主席。
Additional information on the Board of Directors and individual Board members can be found here:
有关董事会和个别董事会成员的更多信息，请点击此处：
About Susan G. Komen
关于 Susan G. Komen
Susan G. Komen is the world's leading nonprofit breast cancer organization, working to save lives and end breast cancer forever. Komen has an unmatched, comprehensive 360-degree approach to fighting this disease across all fronts and supporting millions of people in the U.S. and in countries worldwide. We advocate for patients, drive research breakthroughs, improve access to high-quality care, offer direct patient support and empower people with trustworthy information. Founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy's life, Komen remains committed to supporting those affected by breast cancer today, while tirelessly searching for tomorrow's cures. Visit komen.org or call 1-877 GO KOMEN. Connect with us on social at .
苏珊·G·科门 是世界领先的非营利性乳腺癌组织，致力于拯救生命并永远终结乳腺癌。Komen采用无与伦比的、全面的360度方法来全方位抗击这种疾病，为美国和全球各国的数百万人提供支持。我们倡导患者，推动研究突破，改善获得高质量护理的机会，为患者提供直接支持，并为人们提供可信的信息。Komen由南希·布林克创立，她向姐姐苏珊·科门保证，她将终结夺去Suzy生命的疾病，她仍然致力于支持当今受乳腺癌影响的人，同时不懈地寻找明天的治疗方法。访问 komen.org 或致电 1-877 GO KOMEN。在社交网站上与我们联系.
Contact:
Cristobal Martinez
[email protected]
联系人：
克里斯托瓦尔·马丁内斯
[电子邮件保护]
SOURCE Susan G. Komen
来源 Susan G. Komen
译文内容由第三方软件翻译。